Literature DB >> 22539663

Editorial commentary: Primary maternal cytomegalovirus infection during pregnancy: do we have a treatment option?

Stuart P Adler.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22539663     DOI： 10.1093/cid/cis425

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  5 in total

1.  Intrauterine growth restriction caused by underlying congenital cytomegalovirus infection.

Authors:  Lenore Pereira; Matthew Petitt; Alex Fong; Mitsuru Tsuge; Takako Tabata; June Fang-Hoover; Ekaterina Maidji; Martin Zydek; Yan Zhou; Naoki Inoue; Sanam Loghavi; Samuel Pepkowitz; Lawrence M Kauvar; Dotun Ogunyemi
Journal:  J Infect Dis       Date:  2014-01-07       Impact factor: 5.226

2.  Advances in the Development of Therapeutics for Cytomegalovirus Infections.

Authors:  Edward Acosta; Terry Bowlin; Jennifer Brooks; Lillian Chiang; Islam Hussein; David Kimberlin; Lawrence M Kauvar; Randi Leavitt; Mark Prichard; Richard Whitley
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

3.  A high-affinity native human antibody neutralizes human cytomegalovirus infection of diverse cell types.

Authors:  Lawrence M Kauvar; Keyi Liu; Minha Park; Neal DeChene; Robert Stephenson; Edgar Tenorio; Stote L Ellsworth; Takako Tabata; Matthew Petitt; Mitsuru Tsuge; June Fang-Hoover; Stuart P Adler; Xiaohong Cui; Michael A McVoy; Lenore Pereira
Journal:  Antimicrob Agents Chemother       Date:  2014-12-22       Impact factor: 5.191

4.  Antibody inhibition of human cytomegalovirus spread in epithelial cell cultures.

Authors:  Xiaohong Cui; Ronzo Lee; Stuart P Adler; Michael A McVoy
Journal:  J Virol Methods       Date:  2013-05-10       Impact factor: 2.014

5.  Fetal and maternal outcome after hyperimmunoglobulin administration for prevention of maternal-fetal transmission of cytomegalovirus during pregnancy: retrospective cohort analysis.

Authors:  Vera Seidel; Max Hackelöer; Rebecca C Rancourt; Wolfgang Henrich; Jan-Peter Siedentopf
Journal:  Arch Gynecol Obstet       Date:  2020-08-04       Impact factor: 2.344
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.